ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

ARID3A promotes the chemosensitivity of colon cancer by inhibiting AKR1C3

Li, Yafei; Tang, Jing; Li, Jing; Du, Yaru; Bai, Fuqiang; Yang, Lirui; Li, Xiaobo; Jin, Xiaoming*; Wang, Tianzhen*哈尔滨医科大学
CELL BIOLOGY INTERNATIONAL2022-6DOI: 10.1002/cbin.11789
1被引4阅读
引用收藏
分享

摘要

ARID3A is upregulated in colorectal cancer and can promote the proliferation and metastasis of cancer cells. However, patients with higher level of ARID3A have a better prognosis. This study aimed to uncover the mechanism by which ARID3A benefits the prognosis of colon cancer. Our results indicated that ARID3A upregulation enhanced the chemosensitivity of colon cancer cells to 5-fluorouracil (5-FU), whereas ARID3A downregulation inhibited the chemosensitivity of colon cancer cells to 5-FU. Through database analysis, we found that AKR1C3, a drug resistance-related gene, was the target of ARID3A. Moreover, AKR1C3 was downregulated in colon cancer tissues compared to normal tissues. Next, we assessed the interaction between AKR1C3 and ARID3A, and found that ARID3A inhibited the transcription of AKR1C3, leading to the downregulation of AKR1C3 in colon cancer cells. We also verified that AKR1C3 inhibited the chemosensitivity of colon cancer cells to 5-FU. Moreover, patients with higher ratio of ARID3A to AKR1C3 had a better prognosis. This study suggested that ARID3A promoted chemosensitivity of colon cancer cells by inhibiting AKR1C3 in colon cancer. The ratio of ARID3A to AKR1C3 is a good marker to predict the prognosis of colon cancer patients.

学科与关键词

关键词
ARID3Achemosensitivitycolon cancer
相关
加载中…
  • ARID3A promotes the development of colorectal cancer by upregulating AURKA
    Tang, Jing; Yang, Lirui; Li, Yafei; Ning, Xuelian; Chaulagain, Anita; Wang, Tianzhen*; Wang, Dong*Carcinogenesis, 2021, 42(4): 578-586.被引 19
  • The Activation of the Tumor Suppressor Protein p53 by Acriflavine Leads to Mitochondrial Dysfunction and Improves the Radiosensitivity of Colon Cancer Cells
    Lin, Caizhao; Chen, Xiaohua; Qiu, Huayun; Li, Benfeng; Guo, Min*Journal of Immunology Research, 2022, 2022: 1328542.被引 1
  • Knockdown of DNA binding protein A (dbpA) enhances the chemotherapy sensitivity of colorectal cancer via suppressing the Wnt/β-catenin/Chk1 pathway.
    Tong, Cong; Qu, Kai; Wang, Guorong; Liu, Ruiting; Duan, Baojun; Wang, Xiaoqiang; Liu, ChangCELL BIOLOGY INTERNATIONAL, 2020.
查看全部 →

发表信息

论文状态
公开发表
期刊
CELL BIOLOGY INTERNATIONAL
发表日期
2022-06
卷期
第 46 卷, 第 6 期
页码
965-975
DOI
10.1002/cbin.11789
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81871976]; Natural Science Foundation of Heilongjiang Province [ZD2020H001]

作者

  • L

    Li, Yafei (第一作者)

    harbin med univ

  • T

    Tang, Jing

    harbin med univ

查看全部 9 位作者收起作者
  • L

    Li, Jing

    harbin med univ

  • D

    Du, Yaru

    harbin med univ

  • B

    Bai, Fuqiang

    harbin med univ

  • Y

    Yang, Lirui

    harbin med univ

  • L

    Li, Xiaobo

    harbin med univ

  • J

    Jin, Xiaoming (通讯)

    harbin med univ

  • W

    Wang, Tianzhen (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417